Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 230
  • Start Date: March 26, 2021
A First-in-human, Phase 1, Randomized, Observer-blind, Controlled Study to Assess the Safety and Immunogenicity of Novel Live Attenuated Type 1 and Type 3 Oral Poliomyelitis Vaccines in Healthy Adults
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 464
  • Start Date: March 16, 2021
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix®, and When Administered Alone or Concomitantly With 9vHPV and Tdap-IPV Vaccines in Healthy Adolescents
Search for trials
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Device, Behavioral
  • Participants: 200
  • Start Date: March 1, 2021
The Health and Behavioural Impact of Implementing SAFEWATER Systems for Drinking Water Disinfection Within Rural Communities in Colombia and Mexico; Mexico
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Behavioral, Device
  • Participants: 84
  • Start Date: March 1, 2021
The Health and Behavioural Impact of Implementing SAFEWATER Systems for Drinking Water Disinfection Within Rural Communities in Colombia and Mexico; Colombia.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 795
  • Start Date: February 8, 2021
Immunogenicity of Novel Monovalent Oral Poliovirus Vaccine Type 2 (nOPV2) With and Without Bivalent OPV
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 350
  • Start Date: January 27, 2021
Immune Response to Pertussis After Vaccination With a Tdap-IPV Booster Vaccine in Children in the Republic of South Africa: Effect of Homologous and Heterologous Pertussis Vaccination Priming Background
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 300
  • Start Date: November 20, 2020
Evaluation of the Persistence of the Immunity in 4-year-old Children Previously Immunised With an Adjuvanted Reduced Dose Inactivated Polio Vaccine, IPV-Al AJV (Picovax®) by Measuring the Response to an Additional Dose of IPV-Al AJV
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 300
  • Start Date: November 15, 2020
A Proof-of-concept Study of Poliovirus Vaccine (IPV) Activity to Induce an Immune Response That Cross-reacts With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 600
  • Start Date: November 13, 2020
A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Immunogenicity and Safety of Combined Immunization of Sabin-strain Inactivated Polio Vaccine (sIPV), Diphtheria, Tetanus, Pertussis Vaccine (DTaP) and Measles, Moms and Rubella Vaccine (MMR)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 600
  • Start Date: November 11, 2020
A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of Sabin-strain Inactivated Polio Vaccine (sIPV), Diphtheria, Tetanus, Pertussis (DTaP) Vaccine and Live Attenuated Hepatitis A Vaccine (HepA)
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 300
  • Start Date: November 5, 2020
Immunogenicity and Safety of the Booster Dose of Polio Vaccine Immunization Using Sabin IPV or bOPV at Children Aged 4 Years With Different Three Sequential Schedules History by Sabin IPV or bOPV in China
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 3
  • Intervention Type: Combination Product, Drug, Biological
  • Participants: 3600
  • Start Date: November 1, 2020
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Polio Vaccine and NA-831 for Prophylaxis and Treatment of Early Onset of Covid-19
Showing 1-12 of 37